Why the study?
Does the LLHPT assay provide comparable precision to the XaI assay for measuring heparin concentration in whole blood and plasma?
Does the LLHPT assay provide comparable precision to the XaI assay for measuring heparin concentration in whole blood and plasma?
The LLHPT assay provides rapid, precise in vitro monitoring of heparin concentration comparable to the XaI assay, suggesting potential utility for bedside monitoring.
Answers are grounded in this paper and cite their sources.
LLHPT may enable rapid heparin monitoring comparable to XaI in vitro; animal data leave clinical adoption unproven.
When unfractionated heparin is used for therapeutic anticoagulation, the heparin effect must be monitored to avoid thrombotic or hemorrhagic complications. The ability of a factor Xa inhibition (XaI) assay was compared with that of a low-level heparin protamine titration (LLHPT) assay to measure the concentration of heparin after heparin was added in vitro to specimens of plasma and whole blood. Heparin effect on the activated partial thromboplastin time also was assessed in the same specimens. The XaI and LLHPT assays had comparable precision and provided linear results over a wide range of heparin concentrations. Both assays slightly underestimated the total amount of heparin added to the specimens. The most rapid test was the whole blood LLHPT assay; this test therefore may be useful for bedside monitoring of heparin. A significant disadvantage of the LLHPT assay was the large sample size required to perform it. These results provide in vitro evidence that the XaI and LLHPT assays can provide equally precise monitoring of heparin concentration.
No takes yet. Share an insight, caveat, or question.
Schlueter et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: